Health Care Equipment & Services

Hinge Health insiders sell 1,200 shares at $88.23 – routine liquidity, not a warning. Investors see confidence, long‑term focus, and steady growth.

Insider sales by Myomo’s CMO hint at cautious outlook—learn why recent Rule 144 moves could signal short‑term pressure on MYOMO’s price and investor sentiment.

Investor alert: Robinson Elliott’s latest small‑block sale shows routine liquidity, not a warning for Hinge Health’s solid upside.

Insight on SOPHiA GENETICS: Valente Manuela’s $3.20 buy during a 15% rally signals insider confidence in the company’s undervalued stock and future growth.

Insider activity at CERIBELL shows CFO Blumberg Scott buying after a 52‑week high and selling for profit, signaling confidence and compliance for investors.

Chao Xingjuan’s August 18 insider sale of 2,199 CeriBell shares is routine, reflecting a 10b5‑1 plan – not a warning, but a signal of steady long‑term confidence.

Senseonics insider ROEDER DOUGLAS A buys 13,953 shares at $8.98, signaling bullish confidence in the company’s expanding glucose‑monitoring pipeline and global growth.

Inside view: Teresa De Luca’s latest buy at $14.33 shows cautious confidence in Surgery Partners, amid a steep stock slide and a weak P/E.

Farquhar’s 32,676‑share sale shows disciplined insider liquidity at HEARTFLOW, underscoring confidence amid strong growth and a 83.9% monthly rally.

Debra King’s recent Stryker stock sale is routine insider activity, unlikely to sway prices but signaling solid company fundamentals and governance transparency.